{"id":739772,"date":"2023-03-14T07:36:06","date_gmt":"2023-03-14T11:36:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/"},"modified":"2023-03-14T07:36:06","modified_gmt":"2023-03-14T11:36:06","slug":"optimizerx-authorizes-15-million-share-repurchase-program","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/","title":{"rendered":"OptimizeRx Authorizes $15 Million Share Repurchase Program"},"content":{"rendered":"
\n

ROCHESTER, Mich., March 14, 2023 (GLOBE NEWSWIRE) — OptimizeRx Corp<\/a>. (the \u201cCompany\u201d)\u00a0(Nasdaq: OPRX),\u00a0a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that its Board of Directors has unanimously authorized a share repurchase program, under which OptimizeRx may repurchase up to $15 million of its outstanding common stock.<\/p>\n

\u201cWe are fortunate to start 2023 with a strong working capital position and believe we are firmly placed to benefit from the scalability inherent in having the nation\u2019s largest in workflow point-of-care network; this share repurchase program reflects the long-term confidence we have in our business and our belief that our shares are undervalued,\u201d commented Will Febbo, OptimizeRx CEO.<\/p>\n

\n About OptimizeRx<\/strong>\n <\/p>\n

OptimizeRx provides best-in-class health technology that enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting over 60% of U.S. healthcare providers and millions of their patients through an intelligent technology platform embedded within a proprietary digital point-of-care network, OptimizeRx helps patients start and stay on their medications.<\/p>\n

For more information, follow the Company on\u00a0Twitter<\/a>,\u00a0LinkedIn<\/a>\u00a0or visit www.optimizerx.com<\/a>.\u00a0<\/p>\n

\n Important Cautions Regarding Forward Looking Statements<\/strong>\n <\/p>\n

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as \u201canticipates\u201d, \u201cbelieves\u201d, \u201cestimates\u201d, \u201cexpects\u201d, \u201cforecasts\u201d, \u201cintends\u201d, \u201cplans\u201d, \u201cprojects\u201d, \u201ctargets\u201d, \u201cdesigned\u201d, \u201ccould\u201d, \u201cmay\u201d, \u201cshould\u201d, \u201cwill\u201d or other similar words and expressions are intended to identify these forward-looking statements. All statements that reflect the Company\u2019s expectations, assumptions, projections, beliefs, or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to the Company\u2019s growth, business plans, and future performance. These forward-looking statements are based on the Company\u2019s current expectations and assumptions regarding the Company\u2019s business, the economy, and other future conditions. The Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by applicable law. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other risks summarized in the Company\u2019s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, its subsequent Quarterly Reports on Form 10-Q, and its other filings with the Securities and Exchange Commission.<\/p>\n

\n OptimizeRx\u00a0Contact<\/strong>\u00a0<\/p>\n

Andy D\u2019Silva, SVP Corporate Finance<\/p>\n

\n adsilva@optimizerx.com<\/a>\n <\/p>\n

\n Media Relations Contact<\/strong>\u00a0<\/p>\n

Kimberley Sirk, Media Relations Manager\u00a0<\/p>\n

\n ksirk@optimizerx.com\u00a0<\/a>\n <\/p>\n

\n Investor Relations Contact<\/strong>\n <\/p>\n

Ashley Robinson<\/p>\n

LifeSci Advisors, LLC<\/p>\n

\n arr@lifesciadvisors.com<\/a>\n <\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

ROCHESTER, Mich., March 14, 2023 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the \u201cCompany\u201d)\u00a0(Nasdaq: OPRX),\u00a0a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that its Board of Directors has unanimously authorized a share repurchase program, under which OptimizeRx may repurchase up to $15 million of its outstanding common stock. \u201cWe are fortunate to start 2023 with a strong working capital position and believe we are firmly placed to benefit from the scalability inherent in having the nation\u2019s largest in workflow point-of-care network; this share repurchase program reflects the long-term confidence we have in our business and our belief that our shares are undervalued,\u201d commented Will Febbo, OptimizeRx CEO. About OptimizeRx OptimizeRx provides best-in-class health technology … <\/p>\n

Continue reading “OptimizeRx Authorizes $15 Million Share Repurchase Program”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-739772","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nOptimizeRx Authorizes $15 Million Share Repurchase Program - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OptimizeRx Authorizes $15 Million Share Repurchase Program - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ROCHESTER, Mich., March 14, 2023 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the \u201cCompany\u201d)\u00a0(Nasdaq: OPRX),\u00a0a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that its Board of Directors has unanimously authorized a share repurchase program, under which OptimizeRx may repurchase up to $15 million of its outstanding common stock. \u201cWe are fortunate to start 2023 with a strong working capital position and believe we are firmly placed to benefit from the scalability inherent in having the nation\u2019s largest in workflow point-of-care network; this share repurchase program reflects the long-term confidence we have in our business and our belief that our shares are undervalued,\u201d commented Will Febbo, OptimizeRx CEO. About OptimizeRx OptimizeRx provides best-in-class health technology … Continue reading "OptimizeRx Authorizes $15 Million Share Repurchase Program"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-14T11:36:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4NzQ1NCM1NDU5NTY3IzIwNDk4ODQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-authorizes-15-million-share-repurchase-program\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-authorizes-15-million-share-repurchase-program\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"OptimizeRx Authorizes $15 Million Share Repurchase Program\",\"datePublished\":\"2023-03-14T11:36:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-authorizes-15-million-share-repurchase-program\\\/\"},\"wordCount\":467,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-authorizes-15-million-share-repurchase-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4NzQ1NCM1NDU5NTY3IzIwNDk4ODQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-authorizes-15-million-share-repurchase-program\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-authorizes-15-million-share-repurchase-program\\\/\",\"name\":\"OptimizeRx Authorizes $15 Million Share Repurchase Program - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-authorizes-15-million-share-repurchase-program\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-authorizes-15-million-share-repurchase-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4NzQ1NCM1NDU5NTY3IzIwNDk4ODQ=\",\"datePublished\":\"2023-03-14T11:36:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-authorizes-15-million-share-repurchase-program\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-authorizes-15-million-share-repurchase-program\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-authorizes-15-million-share-repurchase-program\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4NzQ1NCM1NDU5NTY3IzIwNDk4ODQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4NzQ1NCM1NDU5NTY3IzIwNDk4ODQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-authorizes-15-million-share-repurchase-program\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OptimizeRx Authorizes $15 Million Share Repurchase Program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OptimizeRx Authorizes $15 Million Share Repurchase Program - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/","og_locale":"en_US","og_type":"article","og_title":"OptimizeRx Authorizes $15 Million Share Repurchase Program - Market Newsdesk","og_description":"ROCHESTER, Mich., March 14, 2023 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the \u201cCompany\u201d)\u00a0(Nasdaq: OPRX),\u00a0a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that its Board of Directors has unanimously authorized a share repurchase program, under which OptimizeRx may repurchase up to $15 million of its outstanding common stock. \u201cWe are fortunate to start 2023 with a strong working capital position and believe we are firmly placed to benefit from the scalability inherent in having the nation\u2019s largest in workflow point-of-care network; this share repurchase program reflects the long-term confidence we have in our business and our belief that our shares are undervalued,\u201d commented Will Febbo, OptimizeRx CEO. About OptimizeRx OptimizeRx provides best-in-class health technology … Continue reading \"OptimizeRx Authorizes $15 Million Share Repurchase Program\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-14T11:36:06+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4NzQ1NCM1NDU5NTY3IzIwNDk4ODQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"OptimizeRx Authorizes $15 Million Share Repurchase Program","datePublished":"2023-03-14T11:36:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/"},"wordCount":467,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4NzQ1NCM1NDU5NTY3IzIwNDk4ODQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/","name":"OptimizeRx Authorizes $15 Million Share Repurchase Program - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4NzQ1NCM1NDU5NTY3IzIwNDk4ODQ=","datePublished":"2023-03-14T11:36:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4NzQ1NCM1NDU5NTY3IzIwNDk4ODQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4NzQ1NCM1NDU5NTY3IzIwNDk4ODQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-authorizes-15-million-share-repurchase-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"OptimizeRx Authorizes $15 Million Share Repurchase Program"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/739772","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=739772"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/739772\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=739772"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=739772"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=739772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}